Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2008 Sep 8;168(16):1776-82.
doi: 10.1001/archinte.168.16.1776.

Practice-linked online personal health records for type 2 diabetes mellitus: a randomized controlled trial

Affiliations
Randomized Controlled Trial

Practice-linked online personal health records for type 2 diabetes mellitus: a randomized controlled trial

Richard W Grant et al. Arch Intern Med. .

Abstract

Background: Web-based personal health records (PHRs) have been advocated as a means to improve type 2 diabetes mellitus (DM) care. However, few Web-based systems are linked directly to the electronic medical record (EMR) used by physicians.

Methods: We randomized 11 primary care practices. Intervention practices received access to a DM-specific PHR that imported clinical and medications data, provided patient-tailored decision support, and enabled the patient to author a "Diabetes Care Plan" for electronic submission to their physician prior to upcoming appointments. Active control practices received a PHR to update and submit family history and health maintenance information. All patients attending these practices were encouraged to sign up for online access.

Results: We enrolled 244 patients with DM (37% of the eligible population with registered online access, 4% of the overall population of patients with DM). Study participants were younger (mean age, 56.1 years vs 60.3 years; P < .001) and lived in higher-income neighborhoods (median income, $53,784 vs $49,713; P < .001) but had similar baseline glycemic control compared with nonparticipants. More patients in the intervention arm had their DM treatment regimens adjusted (53% vs 15%; P < .001) compared with active controls. However, there were no significant differences in risk factor control between study arms after 1 year (P = .53).

Conclusions: Previsit use of online PHR linked to the EMR increased rates of DM-related medication adjustment. Low rates of online patient account registration and good baseline control among participants limited the intervention's impact on overall risk factor control.

Trial registration: clinicaltrials.gov Identifier: NCT00251875.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flowchart of a clinic-randomized trial comparing type 2 diabetes mellitus (DM) management among patients receiving access to a DM and medications personal health record (intervention arm) vs a family history and health maintenance personal health record (active control arm). Eligible participants had DM and an active Patient Gateway (PG) account for secure Internet access within the health network.
Figure 2
Figure 2
Proportion of follow-up visits with diabetes mellitus–related medication changes among patients who submitted personal health record journals to their physician's electronic medical record (“on-treatment analysis” comparing intervention and control arms).

References

    1. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) Lancet. 1998;352(9131):854–865. - PubMed
    1. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998;317(7160):703–713. - PMC - PubMed
    1. Curb JD, Pressel SL, Cutler JA, et al. Systolic Hypertension in the Elderly Program Cooperative Research Group Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. JAMA. 1996;276(23):1886–1892. - PubMed
    1. Pyorala K, Pedersen TR, Kjekshus J, Faergeman O, Olsson AG, Thorgeirsson G. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease: a subgroup analysis of the Scandinavian Simva-statin Survival Study (4S) Diabetes Care. 1997;20(4):614–620. - PubMed
    1. Gaede P, Vedel P, Larsen N, Jensen GVH, Parving HH, Pedersen O. Multifacto-rial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003;348(5):383–393. - PubMed

Publication types

Associated data